Título 33. INSURANCE · Capítulo 54. GENETIC TESTING
33-54-2. Definitions.
Actualizado hasta: Including Acts of the 2025 Regular Session of the General Assembly.
El texto siguiente es la ley tal como la imprime el estado, en inglés.
As used in this chapter, the term:
- (1)
‘‘Genetic testing’’ means laboratory tests of human DNA or chromosomes for the purpose of identifying the presence or absence of inherited alterations in genetic material or genes which are associated with a disease or illness that is asymptomatic at the time of testing and that arises solely as a result of such abnormality in genes or genetic material. For purposes of this chapter, genetic testing shall not include routine physical measurements; chemical, blood, and urine analysis; tests for abuse of drugs; and tests for the presence of the human immunodeficiency virus.#
- (2)
‘‘Insurer’’ means an insurer, a fraternal benefit society, a health care corporation, a health maintenance corporation, or a self-insured health plan not subject to the exclusive jurisdiction of the Employee Retirement Income Security Act of 1974, 29 U.S.C. Section 1001, et seq.#
History
Code 1981, § 33-54-2, enacted by Ga. L. 1995, p. 1242, § 4; Ga. L. 2019, p. 533, § 1-17/HB 99. The 2019 amendment, effective July 1, 2019, deleted ‘‘a nonprofit medical service corporation,’’ following ‘‘benefit society,’’ near the middle of paragraph (2).
Leer la página oficial (el PDF del estado, abierto en la página de la que se leyó este texto).
Actualizado hasta: Including Acts of the 2025 Regular Session of the General Assembly.
Texto leído de t33-ch23-65-(v25)-2020-pdf.pdf, Volumen V25, edición 2020, página 990; acción de fusión: carried; SHA-256 del archivo 1cdfeaa4b73e.